Brind.

Scinai develops PC111 for SJS/TEN treatment, highlighting the research of Roberta Lotti.

1 report, 1 independent Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Scinai develops PC111 for SJS/TEN treatment, highlighting the research of Roberta Lotti.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireScinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN New data builds on award-winning research and confirms efficacy and safety of